New filler – Belotero Balance – now approved

This week, the FDA approved a new hyaluronic filler, called Belotero Balance.  It’s made by Merz Pharmaceuticals, the makers of scar product Mederma and Botox wanna-be Xeomin.  Belotero has been on the market in Europe in 3 separate formulations, which are designed for different applications.  So far, the U.S. only gets this one version.Like the other HA’s already on the market, Belotero is not permanent.  I believe the duration of treatment from Belotero Balance is similar to that of Juvederm and Restylane.  However, Belotero is the first HA filler to be manufactured with a new cross-linking process, that makes it smoother and less prone to lumpiness.  The technique is called “Cohesive Polydensified Matrix (CPM) technology” – which sounds very Star Trek…and allegedly this method gives the product better elasticity and smoothness.

Various European websites claim this smoothness allows a less painful injection and also gives a nicer feeling initial result for the patient, but I’ll have to see some science on those claims first!  So far, this study suggests that Belotero Basic, one of the 3 European formulations, is equal to or slightly better than Restylane during the first 4 weeks after injection.

We’ll be evaluating this product for use in our injection practice, to add to Restylane, Juvederm, Prevelle Silk, Radiesse and Sculptra.  We’ll keep you posted!

Comments are closed.

Fiala Aesthetics | Plastic Surgery & Med Spa